130 related articles for article (PubMed ID: 23271897)
1. Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.
Nachega JB; Morroni C; Chaisson RE; Goliath R; Efron A; Ram M; Maartens G
Patient Prefer Adherence; 2012; 6():887-91. PubMed ID: 23271897
[TBL] [Abstract][Full Text] [Related]
2. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis.
Li L; Li J; Chai C; Liu T; Li P; Qu M; Zhao H
Int J Clin Exp Pathol; 2021; 14(6):670-679. PubMed ID: 34239668
[TBL] [Abstract][Full Text] [Related]
3. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
4. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
5. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
[TBL] [Abstract][Full Text] [Related]
7. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
8. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.
Rabie H; Violari A; Duong T; Madhi SA; Josipovic D; Innes S; Dobbels E; Lazarus E; Panchia R; Babiker AG; Gibb DM; Cotton MF;
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1194-200, i. PubMed ID: 21943845
[TBL] [Abstract][Full Text] [Related]
9. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).
Stek C; Schutz C; Blumenthal L; Thienemann F; Buyze J; Nöstlinger C; Ravinetto R; Wouters E; Colebunders R; Maartens G; Wilkinson RJ; Lynen L; Meintjes G
JMIR Res Protoc; 2016 Aug; 5(3):e173. PubMed ID: 27571786
[TBL] [Abstract][Full Text] [Related]
10. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
11. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.
Smith K; Kuhn L; Coovadia A; Meyers T; Hu CC; Reitz C; Barry G; Strehlau R; Sherman G; Abrams EJ
AIDS; 2009 Jun; 23(9):1097-107. PubMed ID: 19417581
[TBL] [Abstract][Full Text] [Related]
13. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.
Ali K; Klotz SA
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):198-202. PubMed ID: 21521804
[TBL] [Abstract][Full Text] [Related]
14. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
[TBL] [Abstract][Full Text] [Related]
15. Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Goovaerts O; Jennes W; Massinga-Loembé M; Ondoa P; Ceulemans A; Vereecken C; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
PLoS One; 2015; 10(7):e0133924. PubMed ID: 26208109
[TBL] [Abstract][Full Text] [Related]
16. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes.
Tan HY; Yong YK; Lim SH; Ponnampalavanar S; Omar SF; Pang YK; Kamarulzaman A; Price P; Crowe SM; French MA
Sex Health; 2014 Dec; 11(6):532-9. PubMed ID: 25200957
[TBL] [Abstract][Full Text] [Related]
18. Effects of time of initiation of antiretroviral therapy in the treatment of patients with HIV/TB co-infection: A systemic review and meta-analysis.
Chelkeba L; Fekadu G; Tesfaye G; Belayneh F; Melaku T; Mekonnen Z
Ann Med Surg (Lond); 2020 Jul; 55():148-158. PubMed ID: 32477514
[TBL] [Abstract][Full Text] [Related]
19. The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children.
Orikiiriza J; Bakeera-Kitaka S; Musiime V; Mworozi EA; Mugyenyi P; Boulware DR
AIDS; 2010 Aug; 24(13):2009-17. PubMed ID: 20616700
[TBL] [Abstract][Full Text] [Related]
20. High Activation of γδ T Cells and the γδ2
Pean P; Nouhin J; Ratana M; Madec Y; Borand L; Marcy O; Laureillard D; Fernandez M; Barré-Sinoussi F; Weiss L; Scott-Algara D
Front Immunol; 2019; 10():2018. PubMed ID: 31507608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
